Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
Top Cited Papers
- 1 June 2005
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 365 (9475), 1934-1941
- https://doi.org/10.1016/s0140-6736(05)66659-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- High‐dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphomaCancer, 2003
- Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialThe Lancet, 2002
- Long-Term Results of Blood and Marrow Transplantation for Hodgkin’s LymphomaJournal of Clinical Oncology, 2001
- Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study GroupBlood, 2000
- Autologous hematopoietic cell transplantation in Hodgkin's diseaseTransplantation and Cellular Therapy, 2000
- Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.Journal of Clinical Oncology, 1996
- Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.Journal of Clinical Oncology, 1996
- Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.Journal of Clinical Oncology, 1993
- Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantationBlood, 1991
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990